This week on The Pharmcast, we talk with Dr. June Almenoff, former President, Chief Medical Officer and Board Member of a biotech, which was recently acquired in 2014 by Forest Laboratories for $1.2 billion.
Almenoff helped the company successfully progress its Irritable Bowel Syndrome drug from Phase 2 through the FDA submission, which the FDA approved in 2013.
Everyone talks about learning from failure, but this week, we learn from success. Join us as we sit down with Dr. Almenoff to talk about her story and lessons she learned along the way.
This week in The Pharmcast, we asked two of our top regulatory policy Experts to give us their holiday wish-lists, and top things to watch for in 2017.
Leading the discussion is Dr. Tim Franson, who is the former VP of Global Regulatory Affairs and Global Patient Safety for Eli Lilly & Company, and also happens to be the Chief Medical Officer at YourEncore.
Joining him is Peter Pitts, former FDA Associate Commissioner. Peter was named one of the 300 Most Powerful People in American Healthcare by Modern Healthcare Magazine, and frequently contributes to national media outlets - including CSNBC, Fox News and the Wall Street Journal.
We know it'll be an interesting discussion, and we hope you enjoy.